Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (NCT07779005) titled 'The Shengjing Lung Cancer Cohort (SJ-LCC) Study on Risk Factors for Disease Development and Progression' on Aug. 19.
Study Type: Observational [Patient Registry]
Primary Sponsor: Shengjing Hospital
Condition:
Lung Caner
Recruitment Status: Recruiting
Date of First Enrollment: February 1, 2019
Target Sample Size: 1500
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07779005
Disclaimer: Curated by HT Syndication....